11:19 AM EDT, 05/08/2025 (MT Newswires) -- Knight Therapeutics ( KHTRF ) was at last look on Thursday down 6.6% after it reported first-quarter results.

The specialty and generic drug company recorded a swing to a profit of $2.2 million, or $0.02 per share, compared with a loss of $4.5 million, or $0.04, in the prior year period.

Revenue increased 2% to $88.1 million, driven by growth of key promoted products, partly offset by declines of Knight's mature products and the depreciation of select LATAM currencies.

The company's shares were last seen down $0.40 to $5.67 on the Toronto Stock Exchange.

Price: 5.67, Change: -0.40, Percent Change: -6.59